Dipeptidil Peptidaz- 4 Enzimine Biyokimyasal Yaklaşım

Yıl 2019, Cilt: 28 Sayı: 1, 41 - 50, 31.03.2019

Hülya Leventerler İbrahim Ferhat Ürünsak Nurten Dikmen

Öz

Dipeptidil
peptidaz- 4 (DPP-4, EC 3.4. 14.5 ), 
proteaz ailesinin bir üyesidir. DPP-4 aynı zamanda adenozin deaminaz
bağlayan protein (ADBP) ya da T-hücre aktivasyon antijeni CD26 olarak da
bilinmektedir. Bir serin ekzopeptidaz olan DPP-4; bir proteinin N-terminal
dipeptitin en sonunda yer alan prolin, hidroksiprolin, dehidroprolin ya da
alanin ayrılmasını katalizlemektedir. Enzim kanda, serbest ve bağlı olmak üzere
iki formda bulunmaktadır.

DPP-4’ün  pek çok dokudaki yaygın dağılımı ve
fizyolojik olaylarda rol almasına bağlı olarak çeşitli patolojik durumlarda da
DPP-4 ekspresyonunda ya da aktivitesinde değişiklikler saptanmıştır. Bu
patolojik durumlar: diyabet, psiko-nöroendokrin bozukluklar, otoimmün ve
inflamatuar hastalıklar, enfeksiyon hastalıkları, hematolojik malignansiler,
solid tümörlerdir. Plazmada değişen CD26/DPP-4 aktivitesi ya da derişimleri
fizyolojik ve otoimmün çeşitli patolojik durumlarla ilgili bulunmuştur. Ayrıca tükürük,
serebrospinal, sinoviyal sıvılar, folikül sıvısı, semen ve idrarda da DPP-4
aktivitesi bildirilmiştir. 

Anahtar Kelimeler

Dipeptidil peptidaz-4, adenozin deaminaz bağlayan protein, CD antijeni

Kaynakça

• 1. Klemann C, Wagner L, Stephan M, Hörsten S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4 (DPP4) entanglement in the immune system. Clin Exp Immunol 2016;185:1-21.2. Leicht S, Shipkova M, Klett C, Gert H, Altrock E, Wilhelm J. CD26/dipeptidyl peptidase IV: A comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Clin Biochem 2013 Oct;46(15):1383-8. 3. Itou M, Kawaguchi T, Taniguchi E, Sata M. Dipeptidyl peptidase-4: A key player in chronic liver disease. World J Gastroenterol 2013 April 21;19(15):2298-2306. 4. Hetmanczyk K, Makaruk B, Kierus K, Izdebska S, Abramczuk DP, Pilch B. Monitoring of dipeptidyl peptidase IV (DPP-IV) activity in patients with mucopolysaccharidoses types I and II on enzyme replacement therapy-Results of a pilot study. Clin Biochem 2016;49:458-462. 5. Aemaimanan P, Sattayasai N, Wara-aswapati N, Pitiphat W, Suwannarong W, Prajaneh S. Alanine aminopeptidase and Dipeptidyl Peptidase IV in saliva of chronic periodontitis patients. J Periodontol 2009 November 80;11:1809-1814.6. Ohnuma K, Marimoto C. Dipeptidyl-peptidase 4. Atlas Genet Cytogenet Oncol Haematol 2012;301-312. 7. Engel M, Hoffman T, Wagner L, Wermann M, Heiser U, Kiefersaver R. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Biochemistry 2013 April 29;100:5063-5068 8. Gorrell MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci 2005;108:277-292.9. Pro B, Dang NH. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol 2004;19:1345-1351. 10. Cheng HC, Abdel-Ghany M, Pauli BU. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 2003;278:24600–24607. 11. Wesley UV, McGroarty M, Homoyouni A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res 2005;65:1325–1334. 12. Gorrell MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (Lond) 2005;108:277–292. 13. Sato T, Yamochi T, Yamochi T, Aytac U, Ohnuma K, McKee KS, Morimoto C, Dang NH. CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299. Cancer Res 2005;65:6950–6956. 14. Conarello SL, Li Z, Ronan J, Roy RS, Zhu L, Jiang G, Liu F, Woods J, Zycband E, Moller DE, et al. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl Acad Sci USA.2003;100:6825–6830. 15. Hildebrandt M, Reutter W, Arck P, Rose M, Klapp BF. A guardian angel:the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence. Clin Sci (Lond) 2000;99:93-104. 16. Umetsu DT, McIntire JJ, Akbari O, Maconubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002;3:715-20. 17. Lun SWM, Wong CK, Ko FWS, Hui DSC, Lam CWK. Increased expression of plasma and CD+T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J Clin Immunol 2007;27:430-7.18. Reinhold D, Biton A, Pieper S. Dipeptidyl peptidase IV (DPIV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation. Int Immunopharmacol 2006;6:1935-42.19. Ulusoy H, Kamanli A, İlhan N. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis. Rheumatol Int 2011;32:3857-62. 20. Sromova L, Marackova H, Sedova L, BalaziovaA, Sedo A. Dipeptidyl peptidase-IV in synovial fluid mononuclear cells of patients with rheumatoid arthritis. Clin Chim Acta 411(2010):1046-1050. 21. Hildebrandt M, Rose M, Rüter J, Salama A, Mönnikes H, Klapp BF. Dipeptidyl peptidase IV (DPIV, CD26) in patients with inflammatory bowel disease. Scand J Gastroenterol 2001;36:1067-72. 22. Tsuji T, Sugahara K, Tsuruda K, Uemura A, Harasawa H, Hasegawa H et al. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Int J Hematol 2004 Oct;80(3):254-60. 23. Carbone A, Cozzi M, Gloghini A, Pinto A. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset T- cell non-Hodgkin's lymphomas. Hum Pathol 1994 Dec;25(12):1360-5. 24. Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 2001 Jan;144(1):125-35. 25. Ho L, Aytac U, Stephens LC,Ohnuma K,Mills GB, McKee KS et al. In vitro and in vivo Antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. Clin Cancer Res 2001 Jul;7(7):2031- 40. 26. Cheng HC, Abdel-Ghany M, Elble RC, Pauli BU. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface- associated fibronectin. J Biol Chem 1998 Sep 11;273(37):24207-15. 27. Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010 Jun 4;6(6):603-15. doi:10.1016/j.stem.2010.04.001. 28. Asada Y, Aratake Y, Kotani T, Marutsuka K, Araki Y, Ohtaki S et al. Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathology 1993 Sep;23(3):265-70.29. Stecca BA, Nardo B, Chieco P, Mazziotti A, Bolondi L, Cavallari A. Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma. J Hepatol 1997 Aug;27(2):337-45.30. Sedo A, Malik R, Krepela E. Dipeptidyl peptidase IV in C6 rat glioma cell line differentiation J Biol Chem 1998 Jan;379(1):39-44.31. Wilson MJ, Ruhland AR, Quast BJ, Reddy PK, Ewing SL, Sinha AA.Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl 2000 Mar-Apr;21(2):220-6.32. Kotani T, Aratake Y, Ogata Y, Umeki K, Araki Y, Hirai K et al. Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett 1991 May 24;57(3):203-8.33. Pethiyagoda CL,Welch DR,Fleming TP.Dipeptidyl peptidase IV(DPPIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis 2000;18(5):391-400. 34. Kajiyama H, Kikkawa F, Suzuki T, Shibata K, Ino K, and Mizutani S. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in in ovarian carcinoma. Cancer Res 2002; 62:2753–2757.
• 35. Avogaro A, Kreutzenberg S, Fadini G. Dipeptidyl-peptidase 4 Inhibition: Linking metabolic control to cardiovascular protection. Curr Pharm Des 2014;20:2387-2394.36. Marguet D, Baggio L, Kobayashi T, et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. PNAS 2000;97:6874-79.
• 37. Silva Junior WS, Gudoy-Matos AF, Kraemer-Aguiar LG. Dipeptidyl Peptidase 4: A new link between diabetes mellitus and atherosclerosis? BioMed Res Int 2015;816164:1-10.38. Kim NH, Yu T, Lee DH. The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. BioMed Res Int 2014; 368703:1-10.39. Nongonierma AB, FitzGerald RJ. Features of dipeptidyl peptidase IV (DPP-IV) İnhibitory peptides from dietary proteins. J Food Biochem 2017;12451:1-11.40. Nargis T, Kumar K, Ghosh AR, Sharma A, Rudra D, Sen D. KLK5 induces shedding of DPP4 from circulatory Th17 cells in Type 2 Diabetes Mol Met 2017;9:4.41. Seliger E, Blumenauer V, Heins J, Neubert K, Kaltwasser P, Schöneich C. Detection of dipeptidyl peptidase IV in follicular fluid—initial report. Zentralbl Gynakol 1988;110(20): 1312-4.42. Shimomura Y, Ando H, Frugori K, Kajiyama H, Suzuki M, Iwase A. Possible involvement of crosstalk cell-adhesion mechanism by endometrial CD26/dipeptidyl peptidase IV and embryonal fibronectin in human blastocyst implantation. Mol Hum Reprod 2006;12(8): 491-495.43. Dolanbay EG, Yardımoğlu M, Yalçınkaya E, Hazır Y, Aksoy A, Karaöz E et al. Expression of trophinin and dipeptidyl peptidase IV in endometrial co-culture in the presence of an embryo:A comparative immunocytochemical study.Mol Med Rep 2016 May;13(5):3961-8. 44. Tan CW, Eng B, Lee YH, Tan HH, Lau MSK, Choolani M. CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis. Fertil Steril 2014;102:167-177.45. Burden HP, Holmes CH, Persad R, Whittington K.Prostasomes-their effects on human male reproduction. Hum Reprod Update 2006;12(3):283-292.46. Arienti G, Polci A, Carlini E, Palmerini CA. Transfer of CD26/dipeptidyl peptidase IV (E.C 3.5.4.4) from prostasomes to sperm. FEBS Letters 1997;410:343-346.